EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment

Larissa D Coelho iD, Mirna M D Souza, Geovanni D Cassali, Raphaela A Silva, Maria J N Paiva, André L B Barros iD, Eliane M Teixeira, Josianne N Silveira, Paulo M Z Coelho, Marta M G Aguiar iD, Mônica C Oliveira

Pharmaceutics · 10.03.2023 · 15 (3) · 904

DOI: 10.3390/pharmaceutics15030904 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 10.03.2023. Verfasst von Larissa D Coelho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de Minas Gerais, National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emetic tartar (ET), was used in the treatment of leishmaniasis but its use was discontinued due to its low therapeutic index. Liposomes have been shown to be a promising strategy for delivery of bioactive substances in the region of interest, in order to reduce and/or eliminate undesirable effects. In the present study, liposomes containing ET were prepared and characterized to evaluate acute toxicity as well as their leishmanicidal action using BALB/c mice with an inoculum of Leishmania (Leishmania) infantum. Liposomes were composed of egg phosphatidylcholine and 3ß-[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol, with an average diameter of 200 nm, zeta potential of +18 mV, and ET encapsulated into liposomes at a concentration near 2 g/L. Healthy mice were treated with ET or liposome containing ET (Lip-ET) in a single dose of 16 mg/kg of Sb3+ intravenously and observed for 14 days. The death of two animals in the ET-treated group and no deaths in the Lip-ET-treated group was observed. Higher hepatic and cardiac toxicity were observed in animals treated with ET when compared to animals treated with Lip-ET, blank liposomes (Blank-Lip) and PBS. The study of antileishmanial efficacy was conducted by intraperitoneal administration of Lip-ET, for ten consecutive days. It was observed by limiting dilution that treatments with liposomal formulations containing ET, as well as Glucantime®, led to a significant reduction in parasitic load in spleen and liver (p < 0.05) when compared to the untreated control group.

Schlagwörter

Stichwörter der Autor:innen

acute toxicityantileishmanial efficacyemetic tartarliposomesvisceral leishmaniasis

Autor:innen und Institutionen

  • Department of Pharmaceutical Products, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
  • Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
  • Department of General Pathology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, MG, Brazil.
  • Clinical Research and Public Policy Group on Infectious and Parasitic Diseases, René Rachou Institute, Fundação Oswaldo Cruz-FIOCRUZ, Belo Horizonte 30190-009, MG, Brazil.
  • Rene Rachou Institute, Oswaldo Cruz Foundation (FIOCRUZ), Belo Horizonte 30190-009, MG, Brazil.

ORCID-Profile: Larissa D Coelho, André L B Barros, Marta M G Aguiar

Förderung

  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais
  • National Council for Scientific and Technological Development
  • Fundação de Amparo à Pesquisa do Estado de Minas Gerais—FAPEMIG
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico—CNPq

Zitieren

APA

Coelho, L. D., Souza, M. M. D., Cassali, G. D., Silva, R. A., Paiva, M. J. N., Barros, A. L. B., Teixeira, E. M., Silveira, J. N., Coelho, P. M. Z., Aguiar, M. M. G., & Oliveira, M. C. (2023). Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment. Pharmaceutics, 15(3), 904. https://doi.org/10.3390/pharmaceutics15030904

Vancouver

Coelho LD, Souza MMD, Cassali GD, Silva RA, Paiva MJN, Barros ALB, et al. Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment. Pharmaceutics. 2023;15(3):904. doi:10.3390/pharmaceutics15030904

BibTeX
@article{Coelho2023,
  author = {Coelho, Larissa D and Souza, Mirna M D and Cassali, Geovanni D and Silva, Raphaela A and Paiva, Maria J N and Barros, André L B and Teixeira, Eliane M and Silveira, Josianne N and Coelho, Paulo M Z and Aguiar, Marta M G and Oliveira, Mônica C},
  title = {Emetic Tartar-Loaded Liposomes as a New Strategy for Leishmaniasis Treatment},
  journal = {Pharmaceutics},
  year = {2023},
  volume = {15},
  number = {3},
  pages = {904},
  doi = {10.3390/pharmaceutics15030904}
}
Kostenlos starten →